Clinical Nurse Specialist Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Nicole Busch

Clinical Nurse Specialist, Adult Health Austin, TX Clinical Nurse Specialist

NPI 1073985446 CMS profile 10480122

4100 Duval Rd, Bldg III Suite 200, Austin, TX 78759

Open in the dashboard

General payments

$27,573

416 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Nicole Busch of Austin, TX is reported in the CMS Open Payments database as having received $27,573 across 416 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Clinical Nurse Specialist, Adult Health profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $9,726 80
2024 General $2,478 30
2023 General $2,782 31
2022 General $6,275 142
2021 General $6,312 133

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Nicole Busch
  • Clinical Nurse Specialist, Adult Health median
  • Middle half of Clinical Nurse Specialist, Adult Health
  • National median

In program year 2025, general payments to Nicole Busch were reported at $9,726. Among 446 Clinical Nurse Specialist, Adult Health profiles paid that year, the median was $193 and the middle half received between $61 and $597.

Show as a table
Year Nicole Busch Clinical Nurse Specialist, Adult Health median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $6,312 $133 $48–$445 $132
2022 $6,275 $163 $57–$526 $149
2023 $2,782 $173 $64–$597 $160
2024 $2,478 $171 $54–$575 $164
2025 $9,726 $193 $61–$597 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Boston Scientific Corporation $10,097 106 payments
  2. Abbott Laboratories $7,388 185 payments
  3. Spinal Simplicity, LLC $4,310 30 payments
  4. Medtronic, Inc. $1,575 21 payments
  5. Globus Medical, Inc. $547 11 payments
  6. Nalu Medical, Inc. $545 16 payments
  7. Nevro Corp. $497 8 payments
  8. SPR Therapeutics, Inc $461 3 payments
  9. Painteq LLC $348 2 payments
  10. Relievant Medsystems, Inc. $310 4 payments
  11. Other $1,495 30 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $15,966 374 payments
  2. Travel and Lodging $6,668 32 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,100 3 payments
  4. Education $1,627 3 payments
  5. Consulting Fee $713 2 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $500 2 payments
Products named General payments · program years 2021–2025
  1. HA MINUTEMAN G3-R $4,310 30 payments
  2. PROCLAIM Neuromodulation $3,380 93 payments
  3. General - Therapies $3,260 11 payments
  4. PROCLAIM Structural Heart $1,507 14 payments
  5. Proclaim IPG $1,426 61 payments
  6. WAVEWRITER ALPHA Pain Management $1,166 5 payments
  7. INTELLIS ADAPTIVESTIM $822 14 payments
  8. WAVEWRITER ALPHA WaveWriter Alpha $669 3 payments
  9. PROCLAIM Structural Heart $643 9 payments
  10. Nalu Neurostimulation System $545 16 payments
  11. Other $7,490 133 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

482

Median for Nurse Practitioner: 389

Drug cost

$8,927

Median for Nurse Practitioner: $21,885

Branded share of claims

0%

Median for Nurse Practitioner: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 202 $3,893
Pregabalin Generic 58 $2,209
Baclofen Generic 74 $1,155
Tizanidine Hcl Generic 88 $919
Methocarbamol Generic 21 $460
Cyclobenzaprine Hcl Generic 22 $219
Trazodone Hcl Generic 17 $72

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 14 billing codes

Paid by Medicare

$30,561

Medicare's payments for the services billed

Medicare patients

97

Average age 73

Services billed

390

65 women, 32 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 71%
Ischemic heart disease 30%
Diabetes 29%
Depression 27%
Osteoporosis 23%
Chronic kidney disease 22%
COPD 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

416 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Nurse Specialist, Adult Health in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record